177 related articles for article (PubMed ID: 10093692)
61. Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial.
Binder D; Schweisfurth H; Grah C; Schäper C; Temmesfeld-Wollbrück B; Siebert G; Suttorp N; Beinert T
Cancer Chemother Pharmacol; 2007 Jun; 60(1):143-50. PubMed ID: 17031643
[TBL] [Abstract][Full Text] [Related]
62. Gemcitabine-cisplatin given on day 1 every 3 weeks in advanced non-small cell lung cancer.
Karacetin D; Incekara O
J BUON; 2006; 11(2):181-4. PubMed ID: 17318968
[TBL] [Abstract][Full Text] [Related]
63. Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: result of a dose-intensity study.
Parra HS; Cavina R; Latteri F; Campagnoli E; Morenghi E; Torri W; Brambilla G; Alloisio M; Santoro A
Invest New Drugs; 2007 Feb; 25(1):57-62. PubMed ID: 16699975
[TBL] [Abstract][Full Text] [Related]
64. A dose-escalation study of weekly topotecan, cisplatin, and gemcitabine front-line therapy in patients with inoperable non-small cell lung cancer.
Guarino MJ; Schneider CJ; Grubbs SS; Biggs DD; Himelstein AL; Hogaboom K; Tilak S
Oncologist; 2002; 7(6):509-15. PubMed ID: 12490738
[TBL] [Abstract][Full Text] [Related]
65. Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer.
Chen YM; Perng RP; Whang-Peng J; Wu HW; Lin WC; Tsai CM
Lung Cancer; 2000 Dec; 30(3):199-202. PubMed ID: 11137205
[TBL] [Abstract][Full Text] [Related]
66. Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.
Kakolyris S; Papadakis E; Tsiafaki X; Kalofonos C; Rapti A; Toubis M; Bania E; Kouroussis C; Chainis K; Androulakis N; Agelaki S; Sarra E; Vardakis N; Georgoulias V;
Lung Cancer; 2001 May; 32(2):179-87. PubMed ID: 11325489
[TBL] [Abstract][Full Text] [Related]
67. Phase II study of liposomal cisplatin (Lipoplatin) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer.
Mylonakis N; Athanasiou A; Ziras N; Angel J; Rapti A; Lampaki S; Politis N; Karanikas C; Kosmas C
Lung Cancer; 2010 May; 68(2):240-7. PubMed ID: 19628292
[TBL] [Abstract][Full Text] [Related]
68. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
Herbst RS; Khuri FR; Lu C; Liu DD; Fossella FV; Glisson BS; Pisters KM; Shin DM; Papadimitrakopoulou VA; Kurie JM; Blumenschein G; Kies MS; Zinner R; Jung MS; Lu R; Lee JJ; Munden RF; Hong WK; Lee JS
Cancer; 2002 Jul; 95(2):340-53. PubMed ID: 12124835
[TBL] [Abstract][Full Text] [Related]
69. Biweekly administration of cisplatin/gemcitabine in advanced nonsmall cell lung cancer.
López-Vivanco G; Viteri A; Barceló R; Muñoz A; Rubio I; Mañé JM; Fuente N
Am J Clin Oncol; 2005 Oct; 28(5):501-7. PubMed ID: 16199991
[TBL] [Abstract][Full Text] [Related]
70. Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a phase II study.
Bretti S; Manzin E; Loddo C; Berruti A; Bombaci S; Vellani G; Celano A
Anticancer Res; 2002; 22(5):3039-43. PubMed ID: 12530039
[TBL] [Abstract][Full Text] [Related]
71. Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small-cell lung cancer in a phase II randomized study.
Perng RP; Chen YM; Ming-Liu J; Tsai CM; Lin WC; Yang KY; Whang-Peng J
J Clin Oncol; 1997 May; 15(5):2097-102. PubMed ID: 9164223
[TBL] [Abstract][Full Text] [Related]
72. A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer.
Grossi F; de Marinis F; Gebbia V; Riccardi F; Caffo O; Gamucci T; Ferraù F; Nardi M; Moscetti L; Boni L; Dondi D; Galligioni E
Cancer Chemother Pharmacol; 2012 Feb; 69(2):369-75. PubMed ID: 21833588
[TBL] [Abstract][Full Text] [Related]
73. Cisplatin plus gemcitabine as adjuvant chemotherapy for radically resected non-small-cell lung cancer: a pilot study.
Tibaldi C; Mazzoni E; Arcabasso G; D'Incecco A; Antonuzzo A; Menconi G; Falcone A
Clin Lung Cancer; 2009 Jan; 10(1):53-7. PubMed ID: 19289373
[TBL] [Abstract][Full Text] [Related]
74. A dose-escalation study of irinotecan (CPT-11) in combination with gemcitabine in patients with advanced non-small cell lung cancer previously treated with a cisplatin-based front line chemotherapy.
Kakolyris SS; Kouroussis C; Koukourakis M; Kalbakis K; Mavroudis D; Vardakis N; Georgoulias V
Anticancer Res; 2002; 22(3):1891-6. PubMed ID: 12168889
[TBL] [Abstract][Full Text] [Related]
75. Phase II trial of gemcitabine plus cisplatin in non-small cell lung cancer: a Hoosier Oncology Group study.
Einhorn LH
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-24-S8-26. PubMed ID: 9207312
[TBL] [Abstract][Full Text] [Related]
76. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
Lee DH; Han JY; Cho KH; Pyo HR; Kim HY; Yoon SJ; Lee JS
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1037-44. PubMed ID: 16024178
[TBL] [Abstract][Full Text] [Related]
77. Elderly patients with advanced non-small cell lung cancer. A pase II study with weekly cisplatin and gemcitabine.
Berardi R; Porfiri E; Scartozzi M; Lippe P; Silva RR; Nacciarriti D; Menichetti ET; Tummarello D; Carle F; Piga A; Cellerino R
Oncology; 2003; 65(3):198-203. PubMed ID: 14657592
[TBL] [Abstract][Full Text] [Related]
78. A 3-week schedule of gemcitabine plus cisplatin as induction chemotherapy for Stage III non-small cell lung cancer.
Migliorino MR; De Marinis F; Nelli F; Facciolo F; Ammaturo MV; Cipri A; Belli R; Ariganello O; Diana F; Di Molfetta M; Martelli O
Lung Cancer; 2002 Mar; 35(3):319-27. PubMed ID: 11844608
[TBL] [Abstract][Full Text] [Related]
79. Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension.
He J; Ying W; Yang H; Xu X; Shao W; Guan Y; Jiang M; Wu Y; Zhong B; Wang D; Tucker S; Zhong N
Anticancer Drugs; 2009 Oct; 20(9):838-44. PubMed ID: 19668080
[TBL] [Abstract][Full Text] [Related]
80. Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer.
Park SH; Hong J; Kim YS; Kim Y; Kyung SY; An CH; Lee SP; Park JW; Jeong SH; Park J; Cho EK; Shin DB; Lee JH
Lung Cancer; 2008 Oct; 62(1):72-7. PubMed ID: 18342982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
